日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Updated Erdman reveals tandem repeat copy number is phase-variable and impacts M. tuberculosis adaptation across evolutionary timescales

更新后的Erdman模型揭示串联重复序列拷贝数具有相位可变性，并影响结核分枝杆菌在进化时间尺度上的适应性。

期刊:mSystems
影响因子:4.6
doi:10.1128/msystems.01026-25
Modlin, Samuel J; Thosar, Nachiket; Mejía-Ponce, Paulina M; Lunceford, Raegan L; Makafe, Gaelle Guiewi; Weinrick, Brian; Valafar, Faramarz
发表日期：2026
文献求助 收藏

Corrigendum to "Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC [JTO Clinical and Research Reports Vol. 4 No. 1: 100431]

更正“组织肿瘤突变负荷和突变状态与帕博利珠单抗联合化疗与单纯化疗治疗转移性非小细胞肺癌的临床结果的关联”[JTO临床与研究报告 第4卷 第1期：100431]

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2025.100892
Garassino, Marina C; Gadgeel, Shirish; Novello, Silvia; Halmos, Balazs; Felip, Enriqueta; Speranza, Giovanna; Hui, Rina; Garon, Edward B; Horinouchi, Hidehito; Sugawara, Shunichi; Rodriguez-Abreu, Delvys; Reck, Martin; Cristescu, Razvan; Aurora-Garg, Deepti; Loboda, Andrey; Lunceford, Jared; Kobie, Julie; Ayers, Mark; Piperdi, Bilal; Pietanza, M Catherine; Paz-Ares, Luis
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

What About Nights, Weekends, and Wait Times? Adding an On-Demand Facilitated Telemedicine Buprenorphine Component to a Community-Based Peer Support Outreach Program

那么，夜间、周末和等待时间怎么办？在社区同伴支持外展计划中加入按需远程医疗丁丙诺啡治疗模块

期刊:
影响因子:
doi:10.1177/29767342241311123
Winograd, Rachel P; Brown, Katherine C; Newman, Schyler T; Banks, Devin E; Carpenter, Ryan W; Budesa, Zach; Lunceford, Jennifer; Siddiqui, Saad T; Jasdanwala, Sarfaraz; Wing, Bradley; Orson, Wendy
发表日期：2025
文献求助 收藏

Pembrolizumab for advanced urothelial carcinoma: exploratory ctDNA biomarker analyses of the KEYNOTE-361 phase 3 trial

帕博利珠单抗治疗晚期尿路上皮癌：KEYNOTE-361 III期试验的ctDNA生物标志物探索性分析

期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-024-03091-7
Powles, Thomas; Chang, Yen-Hwa; Yamamoto, Yoshiaki; Munoz, Jose; Reyes-Cosmelli, Felipe; Peer, Avivit; Cohen, Graham; Yu, Evan Y; Lorch, Anja; Bavle, Abhishek; Homet Moreno, Blanca; Markensohn, Julia; Edmondson, Mackenzie; Chen, Cai; Cristescu, Razvan; Peña, Carol; Lunceford, Jared; Gunduz, Seyda
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma

肿瘤突变负荷和PD-L1与帕博利珠单抗联合或不联合化疗治疗晚期尿路上皮癌疗效的相关性

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-23-3518
Fléchon, Aude; Morales-Barrera, Rafael; Powles, Thomas; Alva, Ajjai; Özgüroğlu, Mustafa; Csöszi, Tibor; Loriot, Yohann; Rodriguez-Vida, Alejo; Géczi, Lajos; Cheng, Susanna Y; Fradet, Yves; Oudard, Stéphane; Vulsteke, Christof; Gunduz, Seyda; Mamtani, Ronac; Yu, Evan Y; Montesa Pino, Alvaro; Anido, Urbano; Sendur, Mehmet A N; Gravis, Gwenaelle; Révész, János; Kostorov, Vladimir; Huillard, Olivier; Ma, Junshui; Rajasagi, Mohini; Vajdi, Amir; Lunceford, Jared; Cristescu, Razvan; Imai, Kentaro; Homet Moreno, Blanca; Matsubara, Nobuaki
PD-L1
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC

组织肿瘤突变负荷和突变状态与帕博利珠单抗联合化疗与单纯化疗治疗转移性非小细胞肺癌临床疗效的相关性

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2022.100431
Garassino, Marina C; Gadgeel, Shirish; Novello, Silvia; Halmos, Balazs; Felip, Enriqueta; Speranza, Giovanna; Hui, Rina; Garon, Edward B; Horinouchi, Hidehito; Sugawara, Shunichi; Rodriguez-Abreu, Delvys; Reck, Martin; Cristescu, Razvan; Aurora-Garg, Deepti; Loboda, Andrey; Lunceford, Jared; Kobie, Julie; Ayers, Mark; Piperdi, Bilal; Pietanza, M Catherine; Paz-Ares, Luis
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Biomarkers predictive of response to pembrolizumab in head and neck cancer

预测头颈癌患者对帕博利珠单抗治疗反应的生物标志物

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.5434
Pfister, David G; Haddad, Robert I; Worden, Francis P; Weiss, Jared; Mehra, Ranee; Chow, Laura Q M; Liu, Stephen V; Kang, Hyunseok; Saba, Nabil F; Wirth, Lori J; Sukari, Ammar; Massarelli, Erminia; Ayers, Mark; Albright, Andrew; Webber, Andrea L; Mogg, Robin; Lunceford, Jared; Huang, Lingkang; Cristescu, Razvan; Cheng, Jonathan; Seiwert, Tanguy Y; Bauml, Joshua M
肿瘤
肿瘤免疫
头颈癌
发表日期：2023
文献求助 收藏

Tumor mutational burden predicts the efficacy of pembrolizumab monotherapy: a pan-tumor retrospective analysis of participants with advanced solid tumors

肿瘤突变负荷预测帕博利珠单抗单药治疗的疗效：一项针对晚期实体瘤患者的泛肿瘤回顾性分析

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2021-003091
Cristescu, Razvan; Aurora-Garg, Deepti; Albright, Andrew; Xu, Lei; Liu, Xiao Qiao; Loboda, Andrey; Lang, Lixin; Jin, Fan; Rubin, Eric H; Snyder, Alexandra; Lunceford, Jared
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma

肿瘤突变负荷、炎症基因表达谱和PD-L1表达对头颈部鳞状细胞癌患者帕博利珠单抗治疗反应的影响

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2021-003026
Haddad, Robert I; Seiwert, Tanguy Y; Chow, Laura Q M; Gupta, Shilpa; Weiss, Jared; Gluck, Iris; Eder, Joseph P; Burtness, Barbara; Tahara, Makoto; Keam, Bhumsuk; Kang, Hyunseok; Muro, Kei; Albright, Andrew; Mogg, Robin; Ayers, Mark; Huang, Lingkang; Lunceford, Jared; Cristescu, Razvan; Cheng, Jonathan; Mehra, Ranee
肿瘤
炎症
肿瘤免疫
炎症/感染
PD-L1
细胞生物学
发表日期：2022
文献求助 收藏

First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors

首个抗免疫球蛋白样转录物4髓系特异性抗体MK-4830可消除晚期实体瘤患者的PD-1耐药机制

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-21-2160
Siu, Lillian L; Wang, Ding; Hilton, John; Geva, Ravit; Rasco, Drew; Perets, Ruth; Abraham, Anson K; Wilson, Douglas C; Markensohn, Julia F; Lunceford, Jared; Suttner, Leah; Siddiqi, Shabana; Altura, Rachel A; Maurice-Dror, Corinne
PD-1
免疫/内分泌
发表日期：2022
文献求助 收藏